Shanghai Junshi Bioscience Co.,Ltd.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Shanghai China (2012)

Organization Overview

First Clinical Trial
2016
NCT02857166
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Shanghai Junshi Bioscience Co., Ltd. | Shanghai Junshi Bioscience Co.,Ltd. | Shanghai Junshi Biosciencee Co.,Ltd | Shanghai Junshi Biosciences Co., LTD | Suzhou Junjing BioSciences Co., Ltd. | TopAlliance Biosciences, Inc.